Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
The expected toxicity rate at the maximum tolerated dose in the standard phase I cancer clinical trial design
Seung Ho Kang,
Chul Ahn
Clinical Sciences - Clinical Research Design
Clinical Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The expected toxicity rate at the maximum tolerated dose in the standard phase I cancer clinical trial design'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Maximum Tolerated Dose
100%
Simulation
36%
Sampling
24%
Dose
22%
Error
21%
Time
10%
Medicine & Life Sciences
Clinical Trials, Phase I
70%
Maximum Tolerated Dose
68%
Neoplasms
18%
Selection Bias
11%
Social Sciences
Clinical Trials
61%
simulation
15%
sampling error
13%
performance
4%
time
3%